High proportion of germline BRCA1 and BRCA2 mutations in unselected ovarian cancer

被引：0
|
作者：
Abrahamson, JLA
Vesprini, DJ
Mclaughlin, J
Cole, D
Rosen, B
Bradley, L
Robb, K
Jack, E
Rehal, P
Morris, A
Patterson, C
Fan, I
Brunel, JS
Narod, SA
Risch, HA
机构：
[1] Univ Toronto, Womens Coll Hosp, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Prevent Med, Toronto, ON, Canada
[3] Univ Toronto, Toronto Hosp, Dept Clin Biochem, Toronto, ON, Canada
[4] Univ Toronto, Toronto Hosp, Dept Gynecol, Toronto, ON, Canada
[5] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 61卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
312
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [21] Tubo-Ovarian Cancer Histoypes in Patients With Germline BRCA1 or BRCA2 Mutations
    Gilks, C. Blake
    McCluggage, W. Glenn
    Brady, Aidan
    Singh, Naveena
    Hunstman, David
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Rahimi, Kurosh
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 286A - 286A
  • [22] Germline BRCA1 and BRCA2 mutations in Brazilian ovarian and breast cancer patients.
    Maistro, Simone
    Encinas, Giselly
    Nagy, Tauana
    Teixeira, Natalia
    Katayama, Maria Lucia H.
    Gouvea, Ana Carolina R. C.
    Diz, Maria del Pilar E.
    Chammas, Roger
    de Boch, Geertruida H.
    Folgueira, Maria Aparecida A. K.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (01) : 31 - 31
  • [23] Tubo-Ovarian Cancer Histotypes in Patients With Germline BRCA1 or BRCA2 Mutations
    Gilks, C. Blake
    McCluggage, W. Glenn
    Brady, Aidan
    Singh, Naveena
    Huntsman, David
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Rahimi, Kurosh
    [J]. MODERN PATHOLOGY, 2015, 28 : 286A - 286A
  • [24] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Al-Joharah Alhuqail
    Areej Alzahrani
    Hannah Almubarak
    Sarah Al-Qadheeb
    Lamyaa Alghofaili
    Nisreen Almoghrabi
    Hamed Alhussaini
    Ben Ho Park
    Dilek Colak
    Bedri Karakas
    [J]. Breast Cancer Research and Treatment, 2018, 168 : 695 - 702
  • [25] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Alhuqail, Al-Joharah
    Alzahrani, Areej
    Almubarak, Hannah
    Al-Qadheeb, Sarah
    Alghofaili, Lamyaa
    Almoghrabi, Nisreen
    Alhussaini, Hamed
    Park, Ben Ho
    Colak, Dilek
    Karakas, Bedri
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 695 - 702
  • [26] High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
    Fackenthal, James D.
    Zhang, Jing
    Zhang, Bifeng
    Zheng, Yonglan
    Hagos, Fitsum
    Burrill, Devin R.
    Niu, Qun
    Huo, Dezheng
    Sveen, Walmy E.
    Ogundiran, Temidayo
    Adebamowo, Clemet
    Odetunde, Abayomi
    Falusi, Adeyinka G.
    Olopade, Olufunmilayo I.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : 1114 - 1123
  • [27] BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
    Pal, T
    Permuth-Wey, J
    Betts, JA
    Krischer, JP
    Fiorica, J
    Arango, H
    LaPolla, J
    Hoffman, M
    Martino, MA
    Wakeley, K
    Wilbanks, G
    Nicosia, S
    Cantor, A
    Sutphen, R
    [J]. CANCER, 2005, 104 (12) : 2807 - 2816
  • [28] Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations
    Ganguly, Shuvadeep
    Gogia, Ajay
    [J]. LANCET ONCOLOGY, 2022, 23 (07): : E314 - E314
  • [29] A family with three germline mutations in BRCA1 and BRCA2
    Liede, A
    Metcalfe, K
    Offit, K
    Brown, K
    Miller, S
    Narod, SA
    Moslehi, R
    [J]. CLINICAL GENETICS, 1998, 54 (03) : 215 - 218
  • [30] BRCA1 and BRCA2 germline mutations in lymphoma patients
    Yossepowitch, O
    Olvera, N
    Satagopan, JM
    Huang, H
    Jhanwar, S
    Rapaport, B
    Boyd, J
    Offit, K
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (01) : 127 - 131
12345